Latest filings (excl ownership)
15-12B
Securities registration termination
24 Sep 21
EFFECT
Notice of effectiveness
22 Sep 21
EFFECT
Notice of effectiveness
22 Sep 21
S-8 POS
Registration of securities for employees (post-effective amendment)
14 Sep 21
S-8 POS
Registration of securities for employees (post-effective amendment)
14 Sep 21
S-8 POS
Registration of securities for employees (post-effective amendment)
14 Sep 21
S-8 POS
Registration of securities for employees (post-effective amendment)
14 Sep 21
POS AM
Prospectus update (post-effective amendment)
14 Sep 21
POS AM
Prospectus update (post-effective amendment)
14 Sep 21
POSASR
Automatic shelf registration (post-effective amendment)
14 Sep 21
POSASR
Automatic shelf registration (post-effective amendment)
14 Sep 21
8-K
Completion of Acquisition or Disposition of Assets
14 Sep 21
25-NSE
Exchange delisting
14 Sep 21
SC 14D9/A
Tender offer solicitation (amended)
14 Sep 21
SC TO-T/A
Third party tender offer statement (amended)
14 Sep 21
SC 14D9/A
Tender offer solicitation (amended)
7 Sep 21
SC 14D9/A
Tender offer solicitation (amended)
27 Aug 21
SC TO-T/A
Third party tender offer statement (amended)
27 Aug 21
SC 14D9
Tender offer solicitation
16 Aug 21
SC TO-T
Third party tender offer statement
16 Aug 21
10-Q
2021 Q2
Quarterly report
5 Aug 21
SC TO-C
Information about tender offer
3 Aug 21
SC14D9C
Written communication relating to third party tender offer
3 Aug 21
8-K
Tender and Support Agreement
3 Aug 21
8-K
Departure of Directors or Certain Officers
16 Jun 21
CT ORDER
Confidential treatment order
18 May 21
10-Q
2021 Q1
Quarterly report
6 May 21
8-K
Departure of Directors or Certain Officers
20 Apr 21
DEFA14A
Additional proxy soliciting materials
19 Apr 21
DEF 14A
Definitive proxy
19 Apr 21
8-K
Departure of Directors or Certain Officers
23 Mar 21
S-8
Registration of securities for employees
1 Mar 21
10-K
2020 FY
Annual report
1 Mar 21
8-K
Translate Bio Announces Fourth Quarter and Full Year 2020 Financial Results and Highlights Recent Progress
25 Feb 21
CT ORDER
Confidential treatment order
11 Jan 21
8-K
Departure of Directors or Certain Officers
28 Dec 20
8-K
Departure of Directors or Certain Officers
22 Dec 20
10-Q
2020 Q3
Quarterly report
5 Nov 20
8-K
Regulation FD Disclosure
25 Aug 20
S-3ASR
Automatic shelf registration
17 Aug 20
Latest ownership filings
4/A
SETH A KLARMAN
16 Sep 21
SC 13D/A
BAUPOST GROUP LLC/MA
16 Sep 21
4
Everett Rand Sutherland
14 Sep 21
4
Brendan Smith
14 Sep 21
4
Ronald C Renaud JR
14 Sep 21
4/A
Ronald C Renaud JR
14 Sep 21
4
Paul D. Burgess
14 Sep 21
4
Robert M Plenge
14 Sep 21
4
Robert J. Meyer
14 Sep 21
4
Owen Hughes
14 Sep 21
4
George Demetri
14 Sep 21
4
JEAN FRANCOIS FORMELA
14 Sep 21
4
George Demetri
14 Sep 21
4
Daniella Beckman
14 Sep 21
4
Sanofi
14 Sep 21
SC 13G/A
FMR LLC
10 Sep 21
SC 13D
Magnetar Financial LLC
16 Aug 21
3
Sanofi
12 Aug 21
SC 13D
Sanofi
12 Aug 21
SC 13D/A
BAUPOST GROUP LLC/MA
4 Aug 21
4
JEAN FRANCOIS FORMELA
17 Jun 21
4
Daniella Beckman
16 Jun 21
4
Robert M Plenge
16 Jun 21
4
Robert J. Meyer
16 Jun 21
4
Owen Hughes
16 Jun 21
4
George Demetri
16 Jun 21
SC 13G/A
FMR LLC
10 May 21
4
Brendan Smith
20 Apr 21
3
Brendan Smith
20 Apr 21
4
Ronald C Renaud JR
9 Apr 21
4
Everett Rand Sutherland
23 Mar 21
3
Everett Rand Sutherland
23 Mar 21
4
Ronald C Renaud JR
9 Mar 21
4
Richard Wooster
9 Mar 21
4
Ann Barbier
9 Mar 21
4
Paul D. Burgess
9 Mar 21
5
DANIEL LYNCH
16 Feb 21
SC 13G/A
RTW INVESTMENTS, LP
12 Feb 21
SC 13G/A
FMR LLC
8 Feb 21
SC 13G
Sanofi
4 Feb 21